SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,281. The last known price of Bitcoin is 71,086.72423286 USD and is down -3.89 over the last 24 hours. It is currently trading on 12779 active market(s) with $28,515,435,687.36 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp selloff and break below key support levels are dominating discussion, with traders pointing to leveraged-long liquidations and broader risk-off pressure across crypto and tech as possible contributors. The community is split between warnings of further downside and calls to buy an oversold dip or watch for support.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas reiterated that topline results from its Phase 3 REGAL trial of GPS in AML are expected in November after the trial reached its required event milestone, drawing attention to the pending binary readout. Traders are broadly excited about the prospect of positive data and a short squeeze, while speculation about a leak or buyout remains unconfirmed and skeptics stress that results have not been released and the trial outcome is uncertain.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

A widespread Microsoft 365 outage disrupted Outlook, Teams, Copilot and other services, prompting complaints about work interruptions and concern that the prolonged disruption could damage trust or pressure the stock. Some traders speculated about a cyberattack, but the cause was not confirmed, and others questioned why shares held relatively steady.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSCIs decision to remove Strategy from its indexes is fueling concerns about passive fund selling, while Bitcoins decline adds pressure to the stock. Traders debate whether the potential outflows are already priced in and whether the exclusion will materially weaken Strategys Bitcoin-linked financing model.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.03439229 USD and is down -2.16 over the last 24 hours. It is currently trading on 1895 active market(s) with $1,786,076,895.36 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs sharp decline toward the $1 support level amid a broader crypto selloff is dominating discussion, with traders pointing to Bitcoin weakness, inflation and rate concerns, and liquidations. Bears warn of further downside and question Ripples ability to provide catalysts, while some holders view the drop as a buying opportunity and continue accumulating.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,962,604.07029401. The last known price of Zcash is 956.58767703 USD and is down -2.92 over the last 24 hours. It is currently trading on 670 active market(s) with $828,877,374.43 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcashs sharp pullback after a major rally is dominating discussion, with traders debating whether it is a broader crypto-market correction and liquidation flush or a deeper breakdown. Some call the selloff an oversold buying opportunity, while bears point to lost support and continued selling.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs resignation and Colette Kresss interim appointment have rattled NVDA shares, with traders also debating potential China chip-export scrutiny and the companys reliance on Huangs leadership. The community is split between buying the selloff on confidence in Nvidias AI business and avoiding the stock amid leadership and regulatory uncertainty.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels planned prostate-cancer BLA filing has been pushed to mid-2027 amid FDA discussions and assay refinement, prompting a sharp selloff and criticism of managements communication and credibility. Some traders see the delay as a manufacturing and regulatory hurdle rather than a problem with the clinical data, while others remain concerned about execution and the longer wait.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Weakness in Ethereum and broader crypto-linked stocks is weighing on BitMine, while traders also criticize its underperformance and question managements spending, transparency, and buybacks. Some see the stocks discount to its crypto holdings as a buying opportunity, but bearish posts argue falling ETH prices can overwhelm any support from repurchases.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is under pressure as Bitcoin and broader crypto markets sell off, with traders highlighting COINs repeated new lows and weak performance even when Bitcoin stabilizes. Bearish calls dominate, though some see the decline as oversold and are buying the dip.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Indian shares dip, rupee slips to record low on elevated oil prices

Indian shares fell, and the rupee hit an all-time low on Tuesday, as high crude oil prices linked to the Middle East conflict weighed on risk sentiment. The Nifty 50 declined 0.36% to 24,032.80 and the BSE Sensex shed 0.33% to 77,017.79. The rupee slid to 95.4325 per U.S. dollar. Brent crude surged to an intraday high of $115.3 a barrel on Monday after Iran stepped up attacks on the UAE and ships in the Gulf, including several in the Strait of Hormuz. While oil prices eased to about $113 on Tuesday on signs the U.S. Navy is loosening Iran’s grip over the strait, they remain elevated, underscoring persistent macroeconomic risks. Higher crude prices are a negative for the world’s third-largest importer of the commodity, as they add to inflationary pressures and drag economic growth and corporate earnings. “Fresh U.S.-Iran hostilities rattled sentiment, implying that the crude-led market gyrations will persist until clearer signs of a resolution to the conflict emerge,” said Anita Gandhi, head of institutional business at Arihant Capital Markets. “While higher crude prices and a weakening rupee are fuelling record foreign outflows, the absence of any major negative surprises this earnings season is helping cushion the market against sharper losses,” Gandhi said.

Top Gainers & Losers on May 5: Wockhardt, Tata Tech, Gabriel India, Dabur, Adani Green Energy among top gainers

Indian markets showed volatility on May 5 amid escalating US-Iran tensions. The Nifty 50 ended up 0.36%, while the Sensex declined 0.33%. Notable gainers included CreditAccess Grameen and Wockhardt, though profit-taking led to losses in several other stocks.

'Made in India - The story of Desh Bandhu Gupta, Lupin and Indian Pharma' Book Launched in Mumbai

MUMBAI, India , Feb. 9, 2026 /PRNewswire/ -- Made in India , written by Sundeep Khanna and Manish Sabharwal, traces three remarkable journeys: the rise of India's pharma industry, the birth and evolution of Lupin (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) and the extraordinary life of its founder, Desh Bandhu Gupta. Together, the three journeys illuminate how a country once completely dependent on imported medicines became the world's pharmacy. The book shares how an individual's life, shaped early by adversity, growing up without privilege or patronage, unpredictably nurtured hunger and drive, to navigate an unforgiving state, blend national health priorities and global standards, to build a multibillion-dollar enterprise whose medicines reach patients in over 120 countries. (L to R) - Dilip Shanghvi, Sun Pharma; Dr. Yusuf Hamied, Cipla; G.V. Prasad, Dr. Reddy’s; Prof. M. M. Sharma, Ex-(UDCT) ICT; Vinita Gupta, Lupin; Moderator, Manish Sabharwal. Made in India shows the distance travelled by a village boy from Rajasthan, who went on to become a teacher, professor and pharmaceutical employee, before founding a company worth $10 billion.

Wockhardt files marketing application in Europe for its novel antibiotic WCK 5222

WCK 5222 is the first New Chemical Entity (NCE) discovered and developed in India to be submitted for pan-European marketing authorisation, Wockhardt says

Wockhardt shares jump over 4%, extend two-day rally following FDA nod for Zaynich

Wockhardt Ltd shares jumped over 4% to ₹1,533, extending a two-day rally after surging nearly 20% on Tuesday. The rise follows the US FDA’s acceptance of its New Drug Application for Zaynich, a first-in-class antibiotic, marking the first NDA approval for a New Chemical Entity by an Indian pharma company.

Indian Markets Extend Gains For Second Week; Nifty Ends Near 25,300, Sensex Surges Over 1,000 Points

Equity

Optimism over an India–US trade deal and easing geopolitical tensions boosted investor sentiment. Buying in real estate, pharma, and PSU banks offset weakness in metals and tech stocks.


US Biosecure Act Boosts Indian Pharma: CDMO Stocks Gained Upto 5%

The legislation seeks to protect American biotech and health data from potential foreign threats, especially from Chinese firms

Indian Markets Extend Losses For Seventh Session; Wockhardt, Vascon, Hindustan Zinc Shine Amid Weak Close

Investors brace for the RBI’s October 1 policy decision and weekly expiry.


Wockhardt Pharma Shares: SEBI Analyst Says Dip Could Be A Buying Chance As Long As ₹1,400 Holds

The analyst pointed to strong support around ₹1,400 and the 200-day EMA, while highlighting the company’s exit from U.S. generics and a credit rating upgrade as factors boosting confidence ahead of Q2 results in November.

Wockhardt Gains On Zaynich Breakthrough; SEBI RA Sees Technical Strength But Cautions Resistance Near This Level 

The analyst said the stock is showing long-term strength, with support seen between ₹1,520 and ₹1,600.

Wockhardt Ltd. engages in the pharmaceutical business. Its products include formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients. The company was founded by Habil Fakhruddin Khorakiwala in 1967 and is headquartered in Mumbai, India.

Wockhardt Ltd.

Neutral Sentiment

Indian equity markets ended higher, with the Nifty index closing below 25,300, led by buying in real estate, pharma, and PSU banks. Metals and technology were the only indices to end in the red on Friday. Renewed optimism over a potential India–US trade deal before the November deadline, along with easing geopolitical tensions in the Middle East, aided investor sentiment.Benchmarks ended higher for the second straight week, gaining over 1.5% and seeing their biggest weekly gains in three months.&nbsp;On Friday, the Sensex closed 1098 points higher at 82,500, while the&nbsp;<a href="https://stocktwits.com/symbol/NIFTY50.NSE">Nifty 50</a> ended up 103 points at 25,285. Broader markets mirrored the gains, with the Nifty Midcap index rising 0.4% and the Smallcap index gaining 0.6%.The retail investor sentiment surrounding the Nifty 50 remained ‘bullish’ by market close on Stocktwits.<figure class="image"><img style="aspect-ratio:804/97;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_10_154349_png_b11c534be4.webp" alt="Screenshot 2025-10-10 154349.png" width="804" height="97"><figcaption>Nifty sentiment and message volume on Oct 10 as of 4:10 pm IST. | source: Stocktwits</figcaption></figure>Stock MovesTCS was among the top Nifty losers, shedding 1% despite steady performance in the September quarter (Q2) earnings. Tata Communications surged 10% on a sentiment boost as TCS unveiled ambitious AI plans that included setting up a 1 GW data centre in India.&nbsp;Weak Q2 performance dragged Tata Elxsi 3% lower.&nbsp;Pharma stocks such as&nbsp;Divi’s Labs, Piramal Pharma, and Wockhardt gained between 3% and 5% after the US Senate passed the National Defense Authorisation Act (NDAA), which includes an amended version of the Biosecure Act.&nbsp; The legislation seeks to protect American biotech and health data from potential foreign threats, especially from Chinese firms.&nbsp;Textile stocks such as Gokaldas, Indo Count surged over 5% on&nbsp;news reports that India-UK are likely to double trade by 2030Man Industries surged 4% after the Securities Appellate Tribunal (SAT) granted a stay on SEBI’s order against the company, which directed it to deposit 50% of the imposed penalty.And new entrant, WeWork India, ended over 2% lower after a muted listing on the bourses.Stock Calls<a href="https://stocktwits.com/Ca_mayankchandel">Mayank Singh Chandel</a> recommended buying&nbsp;<a href="https://stocktwits.com/symbol/LTFOODS.NSE">LT Foods</a>. The stock has found support at a rising trendline and is currently trading just below its 200-day Exponential Moving Average (EMA). In the past, the stock has bounced back from the 200 EMA or slightly below it, demonstrating strong support at this level, which makes the current price a good entry point.&nbsp;He suggested entering at the current market price with a stop loss below ₹375. Short-term price target is set at ₹420, with a medium-term target at ₹500.<stembedurl>https://stocktwits.com/Ca_mayankchandel/message/631777420</stembedurl><a href="https://stocktwits.com/investkaps">Kapil Aggarwal of InvestKaps</a> recommended buying AMAL at the current price of ₹950-₹1,000 for a target of ₹1,200 and a stop loss of ₹900. The stock has seen a healthy, well-channeled correction and taken support around its 20-week EMA. It looks poised for an upmove to a new high.<stembedurl>https://stocktwits.com/investkaps/message/631778299</stembedurl>Markets: What Next?Globally, European markets traded mixed, while US stock futures indicate a subdued start on Wall Street as the US government shutdown is likely to extend into next week.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

(Photo by Indranil Aditya/NurPhoto via Getty Images)

Optimism over an India–US trade deal and easing geopolitical tensions boosted investor sentiment. Buying in real estate, pharma, and PSU banks offset weakness in metals and tech stocks.

Current Price	2,053.40
Prev Close	2,062.50
Open	2,050.00
Dividend Yield	0.00%
50-Day Moving Average	2,045.69
Beta	N/A
Avg. Volume	587,582.64
PE Ratio	81.40

52-Week High	2,422.30
52-Week Low	1,086.70
Market Capitalization	330.61B
EPS (Annual)	13.11
Price to Book	6.47
Revenue Per Employee	8.12M

Feed

News

Sentiment

Fundamentals

Info

WOCKPHARMA.NSE Fundamentals